2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide

C40H69ClN12O6 — CID 176777420

IUPAC2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide
SMILESCCC(CC)C1CC(N[C@H]2CC[C@H](NCC(=O)NCCCN3CC(CCOCCNC4CCCC5C(=O)N(C6CCC(=O)NC6=O)C(=O)C45)NN3)C2)N2NCC(Cl)C2N1
InChIInChI=1S/C40H69ClN12O6/c1-3-24(4-2)31-20-33(53-37(47-31)29(41)21-45-53)46-26-10-9-25(19-26)44-22-35(55)43-14-6-16-51-23-27(49-50-51)13-17-59-18-15-42-30-8-5-7-28-36(30)40(58)52(39(28)57)32-11-12-34(54)48-38(32)56/h24-33,36-37,42,44-47,49-50H,3-23H2,1-2H3,(H,43,55)(H,48,54,56)/t25-,26-,27?,28?,29?,30?,31?,32?,33?,36?,37?/m0/s1
InChIKeyOAIHJAAUJVGBTO-RKHRRNGTSA-N
MW849.52 g/mol
LogP-0.88
Rot. Bonds20

About 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide

2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide (PubChem CID 176777420) has the molecular formula C40H69ClN12O6 and a molecular weight of 849.52 g/mol. Its IUPAC name is 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide.

Molecular Properties

Compound Name2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide
PubChem CID176777420
Molecular FormulaC40H69ClN12O6
Molecular Weight849.52 g/mol
Exact Mass848.52
IUPAC Name2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide
SMILESCCC(CC)C1CC(N[C@H]2CC[C@H](NCC(=O)NCCCN3CC(CCOCCNC4CCCC5C(=O)N(C6CCC(=O)NC6=O)C(=O)C45)NN3)C2)N2NCC(Cl)C2N1
InChIInChI=1S/C40H69ClN12O6/c1-3-24(4-2)31-20-33(53-37(47-31)29(41)21-45-53)46-26-10-9-25(19-26)44-22-35(55)43-14-6-16-51-23-27(49-50-51)13-17-59-18-15-42-30-8-5-7-28-36(30)40(58)52(39(28)57)32-11-12-34(54)48-38(32)56/h24-33,36-37,42,44-47,49-50H,3-23H2,1-2H3,(H,43,55)(H,48,54,56)/t25-,26-,27?,28?,29?,30?,31?,32?,33?,36?,37?/m0/s1
InChIKeyOAIHJAAUJVGBTO-RKHRRNGTSA-N
XLogP-0.88
TPSA212.57 Ų
H-Bond Donors9
H-Bond Acceptors15
Rotatable Bonds20
Heavy Atoms59
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500849.52
LogP ≤ 5-0.88
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1015

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide?
The IUPAC name of 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide (CID 176777420) is 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide.
What is the SMILES notation for 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide?
The canonical SMILES for 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide is CCC(CC)C1CC(N[C@H]2CC[C@H](NCC(=O)NCCCN3CC(CCOCCNC4CCCC5C(=O)N(C6CCC(=O)NC6=O)C(=O)C45)NN3)C2)N2NCC(Cl)C2N1.
What is the InChIKey of 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide?
The InChIKey is OAIHJAAUJVGBTO-RKHRRNGTSA-N. The full InChI is InChI=1S/C40H69ClN12O6/c1-3-24(4-2)31-20-33(53-37(47-31)29(41)21-45-53)46-26-10-9-25(19-26)44-22-35(55)43-14-6-16-51-23-27(49-50-51)13-17-59-18-15-42-30-8-5-7-28-36(30)40(58)52(39(28)57)32-11-12-34(54)48-38(32)56/h24-33,36-37,42,44-47,49-50H,3-23H2,1-2H3,(H,43,55)(H,48,54,56)/t25-,26-,27?,28?,29?,30?,31?,32?,33?,36?,37?/m0/s1.
What are the key properties of 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide?
2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide has a molecular weight of 849.52 g/mol, XLogP of -0.88, 20 rotatable bonds, 9 hydrogen bond donors, and 15 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(1S,3S)-3-[(3-chloro-5-pentan-3-yl-1,2,3,3a,4,5,6,7-octahydropyrazolo[1,5-a]pyrimidin-7-yl)amino]cyclopentyl]amino]-N-[3-[4-[2-[2-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-3a,4,5,6,7,7a-hexahydroisoindol-4-yl]amino]ethoxy]ethyl]triazolidin-1-yl]propyl]acetamide is sourced from PubChem (CID 176777420), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).